We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Feedback Plc | LSE:FDBK | London | Ordinary Share | GB00BJN59X09 | ORD 50P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 97.50 | 95.00 | 100.00 | 97.50 | 97.50 | 97.50 | 4,188 | 07:36:53 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Electronic Computers | 1.03M | -2.92M | -0.2188 | -4.46 | 13M |
Date | Subject | Author | Discuss |
---|---|---|---|
10/9/2018 18:12 | Deal worth many 10's of thousands. Approximately 8 deals done in Korea, 1st quarter sales have been exceptional. | leetomma | |
10/9/2018 13:36 | I wonder if they will be covering before the "event".? | ducatiman | |
10/9/2018 12:09 | PeteK he no longer works for the Co'. Bo, I do believe there are open short positions here. Best of luck to them, I will stay long. | ducatiman | |
10/9/2018 11:57 | Good Post and very prudent jon,The other poster were referring to another poster not your goodself | botak54 | |
10/9/2018 11:55 | Quite baffling really dont you think PK,Unless that poster is running a short or has gone chicken oriental | botak54 | |
10/9/2018 11:53 | I certainly don't want the share price lower.I just made the point it annoys me when contracts are announced with no numbers! Investors often buy the spike that results only to lose out after the drop! I believe contracts shouldn't be announced unless accompanied with numbers so investors make an informed choice whether to buy or not.When I first saw the RNS I was considering buying but held off when no numbers announced. | jon1962 | |
10/9/2018 11:29 | Well that's a shocker, I wonder if the BoD are aware of his comments here particularly as the company (FBDU) where he is CEO basically relies on Texrad to power their own products. Hmmmm. | petekand | |
10/9/2018 11:19 | Pete. Yes. | lr2 | |
10/9/2018 11:18 | That indeed is what is being suggested Pete. | ducatiman | |
10/9/2018 11:14 | Apologies for my ignorance here but are some of you suggesting ex-dir TB is the troll on this board posting as ydder? If so, I find this quite incredible. Very good news this morning despite the lacklustre market reaction. | petekand | |
10/9/2018 11:09 | I wouldn't put it past TB to have borrowed some stock after his ammo ran dry. He is certainly extremely disgruntled. | ducatiman | |
10/9/2018 10:16 | Biggish (for FDBK) blocks of 500k and 200k being dumped. | cyberbub | |
10/9/2018 10:07 | Seem to be a few people wanting the share price lower for some reason. | ducatiman | |
10/9/2018 09:25 | A knock price on an RNS bundle package eh? Lol | jon1962 | |
10/9/2018 09:05 | Maybe they have paid for a year of RNS as there is so much news to come. Just saying. | ducatiman | |
10/9/2018 08:48 | Frankly its pathetic to be RNS-ing a routine research software sales after years of selling them without any fuss, where's the meat! | ydderf | |
10/9/2018 08:30 | Unless an order is significant it's not worth the cost of RNS in my opinion or all it will achieve is a spike which will then be sold into and not sustained! Happens all too often with aim companies | jon1962 | |
10/9/2018 08:07 | They should say so then but words like significant order could have been used if indeed it was significant. | jon1962 | |
10/9/2018 08:05 | well to be fair, it is good to see this traction, but numbers would also be good. Often they may be prevented via confidentiality agreements etc. | qs99 | |
10/9/2018 07:49 | Who will be suckered in? In previous years there wasn’t an RNS every time a research software sale was made, but now (I wonder why?) we are spending £400 for an RNS announcing every (?) £$20k sale. The rate seems to be just under one per month, which is fewer than in previous years...there can’t be that many medical centres left who haven’t looked at the software over the past four years | ydderf | |
10/9/2018 07:39 | Very irritating when no details of numbers are given! Won't entice me to buy | jon1962 | |
10/9/2018 07:25 | RNS out. Sale of TexRAD to Samsung Medical Centre in South Korea. Apologies but unable to post link at present. | lr2 | |
08/9/2018 08:25 | Any volunteers to create a new feedback medical thread? | ducatiman |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions